References
- ShieldsJAEagleRCJrShieldsCLMarrBPAggressive retinal astrocytomas in 4 patients with tuberous sclerosis complexArch Ophthalmol2005123685686315955990
- MennelSMeyerCHPeterSSchmidtJCKrollPCurrent treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literatureActa Ophthalmol Scand200785212713217305725
- SaitoWKaseSOhgamiKMoriSOhnoSIntravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedemaActa Ophthalmol201088337738018778334
- BloomSMMahlCFPhotocoagulation for serous detachment of the macula secondary to retinal astrocytomaRetina19911144164221813959
- EskelinSTommilaPPalosaariTKiveläTPhotodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomasActa Ophthalmol200886779479918759802
- MennelSHausmannNMeyerCHPeterSPhotodynamic therapy for exudative hamartoma in tuberous sclerosisArch Ophthalmol2006124459759916606894
- ShieldsCLMaterinMAMarrBPKrepostmanJShieldsJAResolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapyArch Ophthalmol2008126227327418268226
- Nguyen-VuPAFacklerIRustALoss of tuberin, the tuberoussclerosis- complex-2 gene product is associated with angiogenesisJ Cutan Pathol200128947047511553313
- ArbiserJLBratDHunterSTuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasmsJ Am Acad Dermatol200246337638011862172